-
4 Top Performing Health Care Stocks With More Upside Potential
Wednesday, July 2, 2014 - 9:47am | 881Read More...Analysts believe that Medtronic (NYSE: MDT), Teva Pharmaceuticals (NYSE: TEVA), UnitedHealth Group (NYSE: UNH) and Zimmer Holdings (NYSE: ZMH) shares still have some headroom, though they all have handily outperformed the S&P 500 over the past six months. They are all dividend payers as well....
-
Johnson & Johnson to Complete Synthes Acquisition
Thursday, June 14, 2012 - 8:25am | 360Read More...Johnson & Johnson (NYSE: JNJ), a leading healthcare and pharmaceutical company, is expected to complete the acquisition of Swiss medical device company on Thursday. The acquisition, expected to cost $19.7 billion, will be Johnson & Johnson's largest deal in history. The purchase will be...
-
Piper Jaffray Reports On Biomet's F3Q
Monday, April 11, 2011 - 7:49am | 78Read More...Piper Jaffray has issued a report regarding the F3Q results from Biomet. According to the report, “Biomet's F3Q ortho results face tougher prior year comps particularly OUS, and will provide the first peek at calendar 2011 hip and knee trends. We expect the trends that impacted the company's metal...
-
Biomet Impacted By US Volume/Europe Price; Hip/Knee Market Expected to Grow 4%
Wednesday, October 13, 2010 - 9:32am | 99Read More...The privately-held Biomet reported slower sequential F1Q11 (August) growth and noted the procedural slowdown during its reported quarter that was discussed by the rest of the orthopedic players in late July on their 2Q calls. “Management discussed slower volume growth beginning in June and going...
